Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
Top Cited Papers
Open Access
- 19 October 2009
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 35 (4) , 830-836
- https://doi.org/10.1183/09031936.00155108
Abstract
In therapeutic studies in idiopathic pulmonary fibrosis (IPF), the low prevalence of significant change in pulmonary functional tests (PFTs) has been a major constraint. The prognostic value of “marginal” changes in PFTs in IPF and fibrotic non-specific interstitial pneumonia (NSIP) was evaluated.In patients with biopsy-proven IPF (n = 84) and NSIP (n = 72), forced vital capacity (FVC) and diffusing capacity of the lung for carbon monoxide (DL,CO) trends at 6 months were categorised as “significant” (FVC >10%;DL,CO>15%) or “marginal” (FVC 5–10%;DL,CO7.5–15%). Proportional hazards analysis and time-dependent receiver operating characteristic methodology were used to examine PFT trends against mortality.In IPF, reductions in FVC were significant in 22 cases (26%) and marginal in 19 cases (23%). Mortality was higher in patients with a significant decline in FVC (hazard ratio (HR) 2.80, 95% CI 1.54–5.06; pDL,COin IPF and marginal changes in FVC andDL,COin fibrotic NSIP did not provide useful prognostic information.Marginal change in FVC in IPF denotes a poor outcome. These findings are applicable to clinical practice and to the selection of patients with more progressive disease for therapeutic studies.Keywords
This publication has 21 references indexed in Scilit:
- A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in sclerodermaArthritis & Rheumatism, 2006
- Cyclophosphamide versus Placebo in Scleroderma Lung DiseaseNew England Journal of Medicine, 2006
- High-Dose Acetylcysteine in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2005
- Fibrotic Idiopathic Interstitial PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Pulmonary Function in Idiopathic Pulmonary Fibrosis and Referral for Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Noninvasive monitoring of airway inflammation.European Respiratory Journal, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patientsThe Journal of Heart and Lung Transplantation, 1999
- Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.American Journal of Respiratory and Critical Care Medicine, 1994